Systemic vascularization in intralobar pulmonary sequestration - congenital or acquired?

M. Montag, G. Albes, M. Arhelger, A. Nemat, G. Stamatis (Essen, Germany)

Source: Annual Congress 2001 - Pulmonary circulation, gas exchange and exercise
Session: Pulmonary circulation, gas exchange and exercise
Session type: Poster Discussion
Number: 3286
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Montag, G. Albes, M. Arhelger, A. Nemat, G. Stamatis (Essen, Germany). Systemic vascularization in intralobar pulmonary sequestration - congenital or acquired?. Eur Respir J 2001; 16: Suppl. 31, 3286

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Two cases of extralobar pulmonary sequestration: a rare congenital malformation
Source: Eur Respir J 2007; 30: Suppl. 51, 171s
Year: 2007

COVID-19 and the pulmonary circulation
Source: ERS webinar 2020: COVID-19 and the pulmonary circulation
Year: 2020


Pulmonary veno-occlusive disease and pulmonary capillary haemangiomatosis
Source: Eur Respir Mon 2012; 57: 182-193
Year: 2012


Pulmonary hypertension in idiopathic pulmonary fibrosis: Utility of HRCT
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014

Diffuse pulmonary development disorders- Molecular definable causes of pulmonary hypertension in the mature newborn
Source: International Congress 2015 – Neonatal and paediatric intensive care
Year: 2015


Central pulmonary arteries in idiopathic pulmonary fibrosis: size really matters
Source: Eur Respir J 2016; 47:1318-1320
Year: 2016


Near-fatal haemoptysis as presentation of a giant intralobar pulmonary sequestration
Source: Eur Respir Rev 2015; 24: 155-156
Year: 2015


Pulmonary hypertension in idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

Sildenafil inhibit dose-dependently profibrotic and remodelling effects of TGFbeta1 on pulmonary arteries from patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis
Source: International Congress 2019 – CCC Airway diseases
Year: 2019



Pulmonary hypertension: a paradigm for rare pulmonary diseases
Source: Eur Respir Rev, 26 (146) 170120; 10.1183/16000617.0120-2017
Year: 2017



Cystic lesions of the lung in children: classification and controversies
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=1
Year: 2007

Precocious detection of pulmonary hypertension in idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012

Congenital pulmonary airway malformations: An important lesson to us all
Source: International Congress 2019 – Paediatric respiratory diseases
Year: 2019

Pulmonary embolism and pulmonary hypertension - is our follow up adequate?
Source: Eur Respir J 2005; 26: Suppl. 49, 270s
Year: 2005

The contributing factors to mean pulmonary artery pressure in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Latest insights into chronic care
Year: 2016


Non-invasive haemodynamic measurement to detect treatment response in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Sildenafil decreases the contractile response to serotonin (5HT) in pulmonary arteries from patients with idiopathic pulmonary fibrosis (IPF) and pulmonary hypertension (PH)
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013